C. Pardoux et al., Downregulation of interleukin-12 (IL-12) responsiveness in human T cells by transforming growth factor-beta: Relationship with IL-12 signaling, BLOOD, 93(5), 1999, pp. 1448-1455
Interleukin-12 (IL-12) is a cytokine that plays a central role in the contr
ol of cell-mediated immunity. We have previously shown that transforming gr
owth factor-beta 1 (TGF-beta) inhibitory effects on human primary allogenei
c cytotoxicity and proliferative responses interfere with IL-12 pathway. Th
e present study was undertaken to further elucidate the biochemical basis o
f the functional interaction between these two cytokines and to define the
site of TGF-beta action on the signaling pathway activated by IL-12, Our da
ta indicate that TGF-beta induced an inhibition of interferon-gamma (IFN-ga
mma) production without affecting the IL-12R beta 1 and IL-12R beta 2 subun
its mRNA expression by activated T cells. We further show that TGF-beta has
a significant inhibitory effect on the early signal transduction events fo
llowing interaction of IL-12 with its receptor on activated T cells, result
ing in the inhibition of both JAK2 and Tyk2 phosphorylation. In addition, T
GF-beta was found to significantly inhibit IL-12-induced phosphorylation of
the STAT4 transcription factor. Electrophoretic mobility shift assay indic
ated that TGF-beta induced a decrease in IL-12-induced STAT4 DNA binding ac
tivity in T lymphocytes. This study suggests that TGF-beta influences IL-12
responsiveness at least in part by inhibiting early signaling events essen
tial to gene induction in IL-12-activated T cells. (C) 1999 by The American
Society of Hematology.